Clinical trial
Recall Enhancement Through Treatment With Atomoxetine in MS (RETAIN-MS)
NCT03091400
Study timeline
Study start (actual)2017-03-16Date precision: day
Registry last updated2020-03-13
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Memory Disordersunresolved
Multiple Sclerosisunresolved
Interventions
AtomoxetineDRUG · verified · RxNorm: atomoxetine
PlaceboDRUG
Sponsors & collaborators
Icahn School of Medicine at Mount Sinailead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03091400 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.